Yuki Gosei KogyoYUKI GOSEI KOGYO CO.,LTD.4531東証スタンダード医薬品FY ending Mar 2026, non-consolidated, J-GAAP
Out of every ¥100 of sales, about ¥3 is left as operating profit. Revenue changed +2.1% from the prior year, operating profit -68.5%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 2.0% | 0.58× | 1.2% | 2.05× | 2.4% |
| 2023 | 4.3% | 0.59× | 2.6% | 2.05× | 5.3% |
| 2024 | 6.0% | 0.56× | 3.3% | 2.10× | 7.0% |
| 2025 | 5.9% | 0.59× | 3.5% | 2.19× | 7.6% |
| 2026 | 2.0% | 0.59× | 1.2% | 2.17× | 2.6% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 12,361 | 12,839 | 12,932 | 15,128 | 15,448 |
| Cost of revenue | 10,005 | 9,790 | 9,672 | 11,820 | 12,827 |
| Gross profit | 2,356 | 3,048 | 3,260 | 3,307 | 2,620 |
| SG&A | 1,942 | 2,151 | 2,134 | 2,091 | 2,236 |
| Operating income | 413 | 897 | 1,125 | 1,216 | 383 |
| Pretax income | 289 | 641 | 905 | 1,124 | 361 |
| Income tax | 41 | 84 | 129 | 228 | 48 |
| Net income attributable to owners | 248 | 556 | 776 | 896 | 313 |
| Operating margin | 3.3% | 7.0% | 8.7% | 8.0% | 2.5% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥1.86B | ¥1.14B | ¥588M | ¥973M | ¥885M |
| Total assets | ¥21.2B | ¥22.1B | ¥24.4B | ¥26.9B | ¥25.7B |
| Net assets | ¥11B | ¥11.5B | ¥12.4B | ¥13.1B | ¥13.5B |
| Share capital | ¥3.47B | ¥3.47B | ¥3.47B | ¥3.47B | ¥3.47B |
| Property, plant and equipment | ¥8.52B | ¥8.82B | ¥9.75B | ¥12B | ¥10.1B |
| Intangible assets excluding goodwill | ¥216M | ¥274M | ¥203M | ¥137M | ¥89M |
| Investment securities | ¥1.51B | ¥1.61B | ¥2.02B | ¥2.05B | ¥2.35B |
| Current assets | ¥10.4B | ¥11B | ¥12.1B | ¥12.5B | ¥13B |
| Current liabilities | ¥6.97B | ¥7.8B | ¥7.99B | ¥7.93B | ¥8B |
| Short-term borrowings | ¥3.5B | ¥3.72B | ¥3.86B | ¥3.6B | ¥1.74B |
| Long-term borrowings | ¥1.16B | ¥825M | ¥2.01B | ¥3.94B | ¥2.39B |
| Total liabilities | ¥10.2B | ¥10.6B | ¥11.9B | ¥13.8B | ¥12.2B |
| Equity attributable to owners of parent | ¥10.3B | ¥10.8B | ¥11.4B | ¥12B | ¥12.2B |
| Retained earnings | ¥3.63B | ¥4.1B | ¥4.73B | ¥5.45B | ¥5.57B |
| Treasury stock | -¥47M | -¥48M | -¥48M | -¥124M | -¥103M |
EDINET (FSA Japan)
有価証券報告書－第106期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第105期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第104期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第103期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第102期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
訂正有価証券報告書－第101期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 49 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.